Company profile for LadRx

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

LadRx is a biopharmaceutical company focused on discovering and developing new therapeutics to treat patients with high unmet needs. LadRx has a milestone and royalty agreement with Orphazyme A/S (Nasdaq - "ORPH") for arimoclomol. Arimoclomol was recently sold to KemPharm, subject to approval on June 1, 2022. The agreement can provide LadRx with potential milestones plus royalties paid on arimoclomol. Orphazyme is currently...
LadRx is a biopharmaceutical company focused on discovering and developing new therapeutics to treat patients with high unmet needs. LadRx has a milestone and royalty agreement with Orphazyme A/S (Nasdaq - "ORPH") for arimoclomol. Arimoclomol was recently sold to KemPharm, subject to approval on June 1, 2022. The agreement can provide LadRx with potential milestones plus royalties paid on arimoclomol. Orphazyme is currently studying arimoclomol in clinical trials for Nieman-Pick disease Type C (NPC) and Gaucher disease

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
11726 San Vicente Blvd. Suite 650 Los Angeles, California 90049
Telephone
Telephone
(310) 826-5648
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20241211915887/en

BUSINESSWIRE
11 Dec 2024

https://pharmafile.com/news/xoma-acquires-royalty-and-milestone-rights-for-npc-and-pancreatic-cancer-assets/

James Spargo PHARMAFILE
23 Jun 2023

https://www.businesswire.com/news/home/20230518005388/en

BUSINESSWIRE
18 May 2023

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty